Auris Medical expects interim analysis of TRAVERS Phase 2 trial in Q4 or 1Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Auris Medical expects top-line data from Phase 1b trial of AM-201 in May
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cara Therapeutics expects interim analysis from Phase 2 trial in AD in Q2
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VBL Therapeutics expects interim analysis of OVAL Phase 3 study in 1Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ProQR Therapeutics expects interim data from Phase 2/2 Stellar trial in 1Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Auris Medical announces interim results from Phase 1b trial with AM-201
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Metracrine achieves enrollment target for MET642 Phase 2a trial interim analysis
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Auris Medical reaches midpoint for enrollment in part B phase 2 trial of AM-125
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Translate Bio Shares Drop After Its mRNA-Based Cystic Fibrosis Candidate Did Not Improve Lung Function
Translate Bio Inc (NASDAQ: TBIO) revealed its second interim analysis from Phase 1/2 clinical trial evaluating MRT5005 in patients with cystic fibrosis (CF). Latest Ratings f.....»»
Allena Pharmaceuticals expects interim analysis for URIROX-2 trial in 2022
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AzurRx BioPharma expects interim data from Phase 2 combination trial in Q3
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Auris Medical says COVID-19 temporarily delays enrollment for TRAVERS trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Auris Medical says Phase 2 trial with AM-125 to be affected by COVID-19
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Can-Fite BioPharma implements interim analysis for Phase 3 Comfort trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aprea Therapeutics expects full enrollment in Phase 3 MDS trial in 1Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Krystal Biotech expects interim results from Phase 1/2 trial of KB105 in 1H20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Auris Medical announces last treatment visit in Phase 1b trial with AM-201
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Forty Seven expects to initiate Phase 1 trial of FSI-174 in 1Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Scholar Rock expects to intiate Phase 1 SRK-181 trial in 1Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Scholar Rock expects interim data from TOPAZ Phase 2 PoC trial in mid-2020
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Evelo expects initial data from EDP1066 Phase 1b trial in 1Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»